SARS-CoV-2 transmission in intercollegiate athletics not fully mitigated with daily antigen testing.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
06 Mar 2021
Historique:
entrez: 10 3 2021
pubmed: 11 3 2021
medline: 11 3 2021
Statut: epublish

Résumé

High frequency, rapid turnaround SARS-CoV-2 testing continues to be proposed as a way of efficiently identifying and mitigating transmission in congregate settings. However, two SARS-CoV-2 outbreaks occurred among intercollegiate university athletic programs during the fall 2020 semester despite mandatory directly observed daily antigen testing. During the fall 2020 semester, athletes and staff in both programs were tested daily using Quidel's Sofia SARS Antigen Fluorescent Immunoassay (FIA), with positive antigen results requiring confirmatory testing with real-time reverse transcription polymerase chain reaction (RT-PCR). We used genomic sequencing to investigate transmission dynamics in these two outbreaks. In Outbreak 1, 32 confirmed cases occurred within a university athletics program after the index patient attended a meeting while infectious despite a negative antigen test on the day of the meeting. Among isolates sequenced from Outbreak 1, 24 (92%) of 26 were closely related, suggesting sustained transmission following an initial introduction event. In Outbreak 2, 12 confirmed cases occurred among athletes from two university programs that faced each other in an athletic competition despite receiving negative antigen test results on the day of the competition. Sequences from both teams were closely related and unique from strains circulating in the community, suggesting transmission during intercollegiate competition. These findings suggest that antigen testing alone, even when mandated and directly observed, may not be sufficient as an intervention to prevent SARS-CoV-2 outbreaks in congregate settings, and highlights the importance of supplementing serial antigen testing with appropriate mitigation strategies to prevent SARS-CoV-2 outbreak in congregate settings. High frequency, rapid turnaround SARS-CoV-2 testing continues to be proposed as a way of efficiently identifying and mitigating transmission in congregate settings. However, here we describe two SARS-CoV-2 outbreaks occurred among intercollegiate university athletic programs during the fall 2020 semester.

Sections du résumé

BACKGROUND BACKGROUND
High frequency, rapid turnaround SARS-CoV-2 testing continues to be proposed as a way of efficiently identifying and mitigating transmission in congregate settings. However, two SARS-CoV-2 outbreaks occurred among intercollegiate university athletic programs during the fall 2020 semester despite mandatory directly observed daily antigen testing.
METHODS METHODS
During the fall 2020 semester, athletes and staff in both programs were tested daily using Quidel's Sofia SARS Antigen Fluorescent Immunoassay (FIA), with positive antigen results requiring confirmatory testing with real-time reverse transcription polymerase chain reaction (RT-PCR). We used genomic sequencing to investigate transmission dynamics in these two outbreaks.
RESULTS RESULTS
In Outbreak 1, 32 confirmed cases occurred within a university athletics program after the index patient attended a meeting while infectious despite a negative antigen test on the day of the meeting. Among isolates sequenced from Outbreak 1, 24 (92%) of 26 were closely related, suggesting sustained transmission following an initial introduction event. In Outbreak 2, 12 confirmed cases occurred among athletes from two university programs that faced each other in an athletic competition despite receiving negative antigen test results on the day of the competition. Sequences from both teams were closely related and unique from strains circulating in the community, suggesting transmission during intercollegiate competition.
CONCLUSIONS CONCLUSIONS
These findings suggest that antigen testing alone, even when mandated and directly observed, may not be sufficient as an intervention to prevent SARS-CoV-2 outbreaks in congregate settings, and highlights the importance of supplementing serial antigen testing with appropriate mitigation strategies to prevent SARS-CoV-2 outbreak in congregate settings.
SUMMARY CONCLUSIONS
High frequency, rapid turnaround SARS-CoV-2 testing continues to be proposed as a way of efficiently identifying and mitigating transmission in congregate settings. However, here we describe two SARS-CoV-2 outbreaks occurred among intercollegiate university athletic programs during the fall 2020 semester.

Identifiants

pubmed: 33688665
doi: 10.1101/2021.03.03.21252838
pmc: PMC7941640
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NLM NIH HHS
ID : T15 LM007359
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):100-105
pubmed: 33476316
J Clin Virol. 2021 Feb;135:104713
pubmed: 33352470
CMAJ Open. 2020 Dec 8;8(4):E819-E824
pubmed: 33293331
J Clin Virol. 2020 Aug;129:104500
pubmed: 32585619
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):130-135
pubmed: 33507889
Disaster Med Public Health Prep. 2020 Sep 10;:1-5
pubmed: 32907679
MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1860-1867
pubmed: 33301434
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):114-117
pubmed: 33507887
N Engl J Med. 2021 Jan 21;384(3):197-199
pubmed: 33472283
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):446-450
pubmed: 32298246
J Clin Microbiol. 2020 Dec 17;59(1):
pubmed: 33023911
Int J Infect Dis. 2020 Oct;99:328-333
pubmed: 32497809
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):141-143
pubmed: 33507895
Clin Infect Dis. 2020 Dec 31;71(11):2920-2926
pubmed: 32548628
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
MMWR Morb Mortal Wkly Rep. 2021 Jan 01;69(5152):1642-1647
pubmed: 33382679
PLoS Pathog. 2021 Feb 26;17(2):e1009373
pubmed: 33635912
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Sci Transl Med. 2020 Dec 9;12(573):
pubmed: 33229462
Nat Commun. 2020 Nov 3;11(1):5558
pubmed: 33144575

Auteurs

Gage K Moreno (GK)

Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison USA 53711.

Katarina M Braun (KM)

Department of Pathobiological Sciences, University of Wisconsin-Madison USA 53711.

Ian W Pray (IW)

Wisconsin Department of Health Services, USA 53703.
Epidemic Intelligence Service, Centers for Disease Control and Prevention USA 30333.

Hannah E Segaloff (HE)

Wisconsin Department of Health Services, USA 53703.
Epidemic Intelligence Service, Centers for Disease Control and Prevention USA 30333.

Ailam Lim (A)

Wisconsin Veterinary Diagnostic Laboratory, University of Wisconsin-Madison USA 53711.

Keith Poulson (K)

Wisconsin Veterinary Diagnostic Laboratory, University of Wisconsin-Madison USA 53711.

Jonathan Meiman (J)

Wisconsin Department of Health Services, USA 53703.

James Borcher (J)

Department of Family Medicine, Division of Sports Medicine, Ohio State University USA 43210.

Ryan P Westergaard (RP)

Wisconsin Department of Health Services, USA 53703.
Department of Medicine, University of Wisconsin-Madison, USA 53711.

Michael K Moll (MK)

Athletic Department, University of Wisconsin-Madison USA 53711.

Thomas C Friedrich (TC)

Department of Pathobiological Sciences, University of Wisconsin-Madison USA 53711.

David H O'Connor (DH)

Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison USA 53711.

Classifications MeSH